The double-blind , placebo-controlled Sildenafil in Treatment-Naive Children , Aged 1 to 17 Years , With Pulmonary Arterial Hypertension ( STARTS-1 ) study assessed sildenafil in pediatric patients with pulmonary arterial hypertension ; improved hemodynamics and exercise capacity occurred in medium - and high-dose groups .